Champions Oncology (STU:2I3) EBITDA Margin % : 28.74% (As of Jan. 2025)

Champions Oncology EBITDA Margin % Chart

Champions Oncology Annual Data
	Trend	Apr15	Apr16	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24
EBITDA Margin %		Get a 7-Day Free Trial					-2.37	3.78	4.55	-4.09	-10.08

Champions Oncology Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EBITDA Margin %	Get a 7-Day Free Trial															-17.44	4.44	12.64	8.38	28.74

Competitive Comparison of Champions Oncology's EBITDA Margin %

For the Biotechnology subindustry, Champions Oncology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Champions Oncology's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Champions Oncology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Champions Oncology's EBITDA Margin % falls into.

Champions Oncology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Champions Oncology's EBITDA Margin % for the fiscal year that ended in Apr. 2024 is calculated as

Champions Oncology's EBITDA Margin % for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Champions Oncology  (STU:2I3) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Champions Oncology EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Champions Oncology's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology Business Description